Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study

Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study

Summary: Background: This study aims to evaluate the association between thromboembolic events and hemorrhagic stroke following BNT162b2 and CoronaVac vaccination. Methods: Patients with incident thromboembolic events or hemorrhagic stroke within 28 days of covid-19 vaccination or SARS-CoV-2 positi...

Full description

Bibliographic Details
Main Authors: Celine Sze Ling Chui, Min Fan, Eric Yuk Fai Wan, Miriam Tim Yin Leung, Edmund Cheung, Vincent Ka Chun Yan, Le Gao, Yonas Ghebremichael-Weldeselassie, Kenneth K.C. Man, Kui Kai Lau, Ivan Chun Hang Lam, Francisco Tsz Tsun Lai, Xue Li, Carlos King Ho Wong, Esther W. Chan, Ching-Lung Cheung, Chor-Wing Sing, Cheuk Kwong Lee, Ivan Fan Ngai Hung, Chak Sing Lau, Joseph Yat Sun Chan, Michael Kang-Yin Lee, Vincent Chung Tong Mok, Chung-Wah Siu, Lot Sze Tao Chan, Terence Cheung, Frank Ling Fung Chan, Anskar Yu-Hung Leung, Benjamin John Cowling, Gabriel Matthew Leung, Ian Chi Kei Wong
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:EClinicalMedicine
Subjects:
Thromboembolic events
Hemorrhagic stroke
Adverse events, BNT162b2
CoronaVac
Online Access:http://www.sciencedirect.com/science/article/pii/S2589537022002346

Internet

http://www.sciencedirect.com/science/article/pii/S2589537022002346

Similar Items